Voluntary recall issued for heart medicine after tests show potential cancer-causing chemical

<p>The pharmaceutical company, Sandoz, is recalling one lot of its losartan.</p>

News 12 Staff

Nov 13, 2018, 3:16 PM

Updated 2,022 days ago

Share:

Voluntary recall issued for heart medicine after tests show potential cancer-causing chemical
The FDA says a pharmaceutical company is voluntarily recalling a heart medicine after tests showed it was tainted with a potential cancer-causing chemical.
The pharmaceutical company, Sandoz, is recalling one lot of its losartan: Sandoz's losartan potassium hydrochlorothiazide 100 milligram/25 milligram tablets with the lot number JB8912.
The active ingredient in the drug tested positive for N-Nitrosodiethylamine or NDEA, a suspected human and animal carcinogen.
The drug is used by patients to keep their high blood pressure in check.
For more information, click here.


More from News 12